INHIBRX BIOSCIENCES INC (INBX) Stock Balance Sheet
NASDAQ:INBX - Nasdaq - US45720N1037 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | N/A | 277.92M | 273.90M | 131.30M | 128.70M | |||
| Receivables | 420.00K | 780.00K | 300.00K | 900.00K | 600.00K | |||
| Other Current Assets | 7.38M | 17.00M | 6.40M | 6.90M | 2.90M | |||
| Total Current Assets | 160.00M | 295.00M | 280.50M | 139.10M | 132.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.00M | 9.37M | 7.20M | 9.50M | 11.30M | |||
| Other Non-Current Assets | 6.83M | 3.16M | 3.20M | 1.80M | 200.00K | |||
| Total Non-Current Assets | 21.00M | 13.00M | 10.40M | 11.40M | 11.50M | |||
| TOTAL ASSETS | 181.00M | 308.00M | 290.90M | 150.50M | 143.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 31.00M | 45.00M | 19.10M | 11.30M | 14.90M | |||
| Accounts Payable | 9.25M | 11.00M | 8.30M | 9.10M | 13.50M | |||
| Other Current Liabilities | N/A | 0.00 | 200.00K | 2.00M | 3.10M | |||
| Total Current Liabilities | 41.00M | 56.00M | 27.60M | 22.50M | 31.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 207.00M | 202.10M | 70.50M | 29.20M | |||
| Other Non-Current Liabilities | 6.45M | 1.11M | 3.20M | 5.10M | 7.60M | |||
| Total Non-Current Liabilities | 6.00M | 208.00M | 205.20M | 75.60M | 36.90M | |||
| TOTAL LIABILITIES | 47.00M | 264.00M | 232.80M | 98.10M | 68.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -106.00M | -614.00M | -372.40M | -227.10M | -145.40M | |||
| Additional Paid In Capital | 240.00M | 657.00M | 430.40M | 279.50M | 220.80M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 0.00 | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 14.00M | 47.00M | 43.60M | 39.00M | 37.70M | |||
| Tangible Book Value per Share | N/A | 0.92 | 1.33 | 1.34 | 2.00 | |||
| Total Shareholders' Equity | 134.00M | 44.00M | 58.10M | 52.40M | 75.50M | |||
| TOTAL LIABILITIES AND EQUITY | 181.00M | 308.00M | 290.90M | 150.50M | 143.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 4.70 | 3.48 | 1.35 | 0.39 | |||
| Current Ratio | 3.90 | 5.27 | 10.16 | 6.18 | 4.21 | |||
| Return On Assets (ROA) | 932.36% | -78.36% | -49.92% | -54.33% | -52.97% | |||
| Return On Equity (ROE) | 1259.38% | -548.55% | -249.97% | -156.05% | -100.82% | |||
All data in USD , ROIC based on taxRate of 0.21